Newsroom

SAN FRANCISCO--(BUSINESS WIRE)--El Fulham Football Club tiene el orgullo de anunciar que ClickHouse, una empresa tecnológica internacional especializada en análisis en tiempo real, infraestructura de datos y aplicaciones de IA, se convierte en su nuevo socio principal y patrocinador principal de la camiseta del primer equipo masculino. Gracias a este acuerdo de colaboración plurianual, ClickHouse ocupará un lugar destacado en la parte delantera de las equipaciones local, visitante y tercera del...

NEW YORK--(BUSINESS WIRE)--Cushman & Wakefield (NYSE: CWK) today announced the return of three senior professionals to its Valuation & Advisory platform, including Chris Sonne, based in Southern California, Greg Becker, MAI, MRICS, based in Tampa, Florida, and Chris Lassiter, based in Nashville, Tennessee. All return as Executive Directors, expanding Cushman & Wakefield’s presence across Southern California and the Southeast. “The return of Chris Sonne, Greg Becker and Chris Lassite...

PARIS--(BUSINESS WIRE)--Nun sind es nur noch wenige Monate bis zur SIAL Paris 2026 (17.–21. Oktober, Paris Nord Villepinte), und die Fachmesse hat die Ergebnisse ihres neuen Berichts „SIAL Insights 2026“ vorgestellt. In dieser internationalen Analyse werden zehn wichtige Trends identifiziert, die den Lebensmittelmarkt und das Verbraucherverhalten nachhaltig verändern werden. Der Bericht, der anhand exklusiver Daten von Kantar Food 360™, Circana und ProtéinesXTC erstellt wurde, beschreibt einen...

LONDON--(BUSINESS WIRE)--  Xtrackers Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-119.899 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 20 July 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, and toge...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Charles Schwab Investment Management, Inc. (CSIM) in its capacity as investment advisor to clients. CSIM expressly disclaims beneficial ownership of the shares described in this form 8.3. (b) Owner or controller of interests and short positions...

NEW YORK--(BUSINESS WIRE)--Native, la société d'intelligence agentique qui construit le système d'exploitation pour le commerce hors ligne, annonce aujourd'hui l'acquisition de Frontline Research Group, une entreprise de renseignement de marché de premier plan au service des entreprises de biens de consommation sur plus de 14 marchés africains. Native acquiert Frontline pour ajouter des données indépendantes sur les parts de marché qui indiquent aux marques si leurs actions commerciales se trad...

PALO ALTO, Calif.--(BUSINESS WIRE)--Genspark.ai today launched Genspark AI Workspace 6.0, its most ambitious release to date. First previewed at the New York Stock Exchange, Genspark AI Workspace 6.0 moves the category beyond one-off content generation toward a system where work does itself. It is powered by a new persistent memory foundation, an enhanced agent suite, and a collaboration layer that treats AI agents as full teammates. "Today, using AI is like collaborating with a genius who has...

GALASHIELS, Schotland & MARLOW, Engeland--(BUSINESS WIRE)--Kyowa Kirin EMEA, een volledige dochteronderneming van Kyowa Kirin Co., Ltd. (TSE:4151), heeft vandaag bekendgemaakt dat de Europese Commissie (EC) een uitbreiding van de indicatie voor Crysvita® (burosumab) voor de behandeling van X-gebonden hypofosfatemie (XLH) heeft goedgekeurd. Zuigelingen van 1 maand tot 1 jaar in de hele Europese Unie en de Europese Economische Ruimte kunnen deze behandeling nu ook krijgen. Deze bekendmaking is of...

GALASHIELS, Scozia e MARLOW, Inghilterra--(BUSINESS WIRE)--Kyowa Kirin EMEA, una controllata al 100% di Kyowa Kirin Co., Ltd. (TSE:4151), ha annunciato oggi che la Commissione europea ha autorizzato un’estensione dell'indicazione terapeutica di Crysvita® (burosumab) per il trattamento dell’ipofosfatemia legata al cromosoma X (XLH), al fine di includere i neonati di età compresa tra 1 mese e 1 anno, in tutta l’Unione europea e nello Spazio economico europeo. Il testo originale del presente annun...

GALASHIELS, Escocia, y MARLOW, Inglaterra--(BUSINESS WIRE)--Kyowa Kirin EMEA, una filial al 100 % de Kyowa Kirin Co., Ltd. (TSE:4151), ha anunciado hoy que la Comisión Europea (CE) ha aprobado la ampliación de la indicación de Crysvita® (burosumab) para el tratamiento de la hipofosfatemia ligada al cromosoma X (XLH), de modo que incluya a los lactantes de entre 1 mes y 1 año de edad en toda la Unión Europea y el Espacio Económico Europeo. El comunicado en el idioma original es la versión oficia...